These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16204634)

  • 1. S6 kinase 2 potentiates interleukin-3-driven cell proliferation.
    Cruz R; Hedden L; Boyer D; Kharas MG; Fruman DA; Lee-Fruman KK
    J Leukoc Biol; 2005 Dec; 78(6):1378-85. PubMed ID: 16204634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1.
    Phin S; Kupferwasser D; Lam J; Lee-Fruman KK
    Biochem J; 2003 Jul; 373(Pt 2):583-91. PubMed ID: 12713446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
    Liu Y; Fanburg BL
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
    Calvo V; Wood M; Gjertson C; Vik T; Bierer BE
    Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL2-dependent phosphorylation of 40S ribosomal protein S6 is controlled by PI-3K/mTOR signalling in CTLL2 cells.
    Tuhácková Z; Sloncová E; Vojtechová M; Sovová V
    Int J Mol Med; 2004 Apr; 13(4):601-5. PubMed ID: 15010863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of S6K2 as a centrosome-located kinase.
    Rossi R; Pester JM; McDowell M; Soza S; Montecucco A; Lee-Fruman KK
    FEBS Lett; 2007 Aug; 581(21):4058-64. PubMed ID: 17678899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.
    Park IH; Bachmann R; Shirazi H; Chen J
    J Biol Chem; 2002 Aug; 277(35):31423-9. PubMed ID: 12087098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.
    Pende M; Um SH; Mieulet V; Sticker M; Goss VL; Mestan J; Mueller M; Fumagalli S; Kozma SC; Thomas G
    Mol Cell Biol; 2004 Apr; 24(8):3112-24. PubMed ID: 15060135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.
    Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z
    Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages.
    Yang CS; Song CH; Lee JS; Jung SB; Oh JH; Park J; Kim HJ; Park JK; Paik TH; Jo EK
    Cell Microbiol; 2006 Jul; 8(7):1158-71. PubMed ID: 16819968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation.
    Shah SA; Potter MW; Ricciardi R; Perugini RA; Callery MP
    J Surg Res; 2001 May; 97(2):123-30. PubMed ID: 11341787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
    Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
    Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.
    Abe Y; Yoon SO; Kubota K; Mendoza MC; Gygi SP; Blenis J
    J Biol Chem; 2009 May; 284(22):14939-48. PubMed ID: 19332537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of S6K2, a novel kinase homologous to S6K1.
    Lee-Fruman KK; Kuo CJ; Lippincott J; Terada N; Blenis J
    Oncogene; 1999 Sep; 18(36):5108-14. PubMed ID: 10490847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
    Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
    Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells.
    Tsai M; Chen RH; Tam SY; Blenis J; Galli SJ
    Eur J Immunol; 1993 Dec; 23(12):3286-91. PubMed ID: 7504992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
    Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.